290
Participants
Start Date
January 31, 2013
Primary Completion Date
June 30, 2024
Study Completion Date
August 30, 2024
Etanercept
Subcutaneous
Infliximab
Infusion
Adalimumab
Subcutaneous
Placebo
Matching Placebo
Georgetown University Medical Center, Washington D.C.
National Institutes of Health Clinical Center, Bethesda
Collaborators (1)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Maryland, Baltimore
OTHER
Washington D.C. Veterans Affairs Medical Center
FED
Medstar Health Research Institute
OTHER
Patient-Centered Outcomes Research Institute
OTHER
Arthritis and Pain Associates of PG County
UNKNOWN
Arthritis & Rheumatism Associates, P.C.
OTHER
Rheumatology Associates of Baltimore, L.L.C.
UNKNOWN
The Arthritis Clinic of Northern Virginia, P.C.
UNKNOWN
Arthritis and Rheumatic Disease Associates, P.C.
UNKNOWN
Georgetown University
OTHER